Bioventus (BVS) Minority Interest (2021 - 2026)

Bioventus (BVS) has 6 years of Minority Interest data on file, last reported at $45.4 million in Q1 2026.

• For the quarter ending Q1 2026, Minority Interest rose 21.51% year-over-year to $45.4 million; the trailing twelve-month figure through Mar 2026 stood at $45.4 million (up 21.51% YoY), and the FY2025 full-year result was $44.3 million, up 17.73% from the prior year.
• Minority Interest for Q1 2026 stood at $45.4 million, up from $44.3 million in the prior quarter.
• Across five years, Minority Interest topped out at $87.0 million in Q4 2022 and bottomed at $35.7 million in Q4 2022.
• The 5-year median for Minority Interest is $45.4 million (2026), against an average of $49.0 million.
• The widest annual swing landed in 2022, when Minority Interest tumbled 54.16%; it then surged 36.86% in 2023.
• A 5-year view of Minority Interest shows it stood at $87.0 million in 2022, then slumped by 45.36% to $47.5 million in 2023, then dropped by 20.75% to $37.7 million in 2024, then rose by 17.73% to $44.3 million in 2025, then rose by 2.3% to $45.4 million in 2026.
• The last three Minority Interest figures came in at $45.4 million (Q1 2026), $44.3 million (Q4 2025), and $41.2 million (Q3 2025), per Business Quant data.

Peer Comparison